ATXN3 and Huntington disease: In contrast to HD mice, the lowering effects of A4(P10A) and A4(P10,11A) shReagents on mutant ATXN3 levels in Ki150Q/21Q mice were only barely significant and showed no clear association with the transduction efficiency of brain structures (Figures 3B and 3C).